Cerevel Therapeutics Holdings, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Cerevel Therapeutics Holdings, Inc. Return On Equity for the quarter ending March 31, 2024 was -98.9 %, a 28.2% decline year-over-year.
  • Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2023 was -100 %, a 49.5% decline from 2022.
  • Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2022 was -67 %, a 36.9% decline from 2021.
  • Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2021 was -48.9 %, a 66.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -100 -33.2 -49.5% Jan 1, 2023 Dec 31, 2023
2022 -67 -18.1 -36.9% Jan 1, 2022 Dec 31, 2022
2021 -48.9 +97.5 +66.6% Jan 1, 2021 Dec 31, 2021
2020 -146 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.